Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sean Janzen who wrote ()	1/25/2000 10:12:00 PM
From: Dick Martin	Read Replies (1) of 1501

I wonder how this discovery about interleukin-9 relates to the research being done by inflazyme? Regards - Dick Martin news.excite.com The study found more of the chemical, known as interleukin-9 (IL-9), in tissue taken from the lungs of people with asthma than in tissue from healthy lungs, they said. Writing in the Journal of Allergy and Clinical Immunology, the team at McGill University in Montreal, Canada, and the Institut Pasteur in Lille, France, said they believed drugs that cancel out the effects of IL-9 might work to help treat asthma. "Based on these results, the previous genetic mapping studies and the biology of IL-9, it is our view that an antibody to IL-9 has significant promise as a therapy for asthma," Dr. Qutayba Hamid, a professor of medicine at McGill who led the study, said in a statement.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next